Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Prostatic NeoplasmsSleep
Interventions
DEVICE

ARESTM

"The ARESTM device is a commercial home sleep-testing device that can record the following parameters (for up to 7 continuous hours) when participants are asleep:~* NREM and REM sleep frequency and duration~* Duration and number of arousal~* Blood oxygen saturation and pulse rate via a silicone-embedded optical sensor~* Fluctuation in nasal airflow pressure via a nasal cannula and pressure transducer~* Head movement actigraphy and flux in snoring as measures of sleep/wake patterns via two accelerometers and an acoustic microphone~* Apnea/hypopnea index and respiratory disturbance index"

Trial Locations (1)

V5Z 1M9

Vancouver Prostate Centre, Vancouver

All Listed Sponsors
lead

Vancouver Prostate Centre

OTHER

NCT02919904 - Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT | Biotech Hunter | Biotech Hunter